Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +21.7% | +40.5% | 3 / 3 | +36.6% | -2.33 pp | -3.71 pp | +29.1% | 0.04 | 7.55 | 129 | +36,6% | 39,1 | +21,7% | 7.55 | 9.06 | −16,7% |
| Pts | 4 | 8 | 12 | 12 | 4 | 0 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 61.100 (close price on 2026-10-19)EPS (TTM): 8.091
Financial charts
1.Revenue & growth
VND bn128Q2/26
1.Revenue & growth
VND bn128Q2/26
2.Profit & growth
VND bn72,7Q2/26
3.Profit mix (Penman)
VND bn256Q2/26
4.Margins & cost structure
%66.2%Q2/26
5.Returns & cash cycle
% · days94.8%Q2/26
6.Earnings quality & cash
VND bn173Q2/26
7.Asset structure
VND bn767Q2/26
8.Funding & debt health
VND bn · times767Q2/26
9.Revenue backlog
VND bn5,34Q2/26
10.Valuation
times · %6,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %3.383Q2/26
Adjusted EPS growth, latest quarter
127%
Average adjusted EPS growth, 3 quarters
75.4%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26